Oracle Expects Over 35% CAGR Through FY30
Oracle expects a compound annual growth rate above 35% from FY26 through FY30.
Related stories
Insmed shares rise after revenue outlook raised
Insmed shares posted their biggest intraday gain in more than two months after the company raised its revenue outlook.
M impact | EARNINGS | Oct 29, 2026, 02:35 PM UTC
Lilly Shares Hit Record High After Raising Forecasts
Lilly shares reached record highs after the company raised forecasts tied to its obesity medicines.
M impact | EARNINGS | Oct 29, 2026, 02:34 PM UTC
Bausch Health Shares Surge 21% on Third-Quarter Beat, Higher Guidance
Bausch Health shares rose 21% after third-quarter profit topped expectations, supported by sales growth for its flagship gastrointestinal drug. The company upgraded its full-year g
M impact | EARNINGS | Oct 29, 2026, 02:33 PM UTC
Basler 9M Sales Rise on Semiconductor and Data-Center Demand; 2026 Outlook Lifted
M impact | EARNINGS | Oct 29, 2026, 02:28 PM UTC
Metsa Board Reports Q3 EBITDA of €25.6 Million
M impact | EARNINGS | Oct 29, 2026, 02:26 PM UTC
Peoples Ltd. Reports Q3 Net Income of $3.323M, Up 10.33% YoY
Peoples Ltd. reported Q3 2026 net income of $3.323 million, or $1.82 per share. Year-to-date net income was $9.882 million, up 35.10% year over year; assets rose 7.38% to $689.2 mi
M impact | EARNINGS | Oct 29, 2026, 02:26 PM UTC